We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

X-Ray Dark-Field Radiography Offers Clues into Lung Disorders

By MedImaging International staff writers
Posted on 12 Jun 2014
Print article
Scientists, for the first time, tested X-ray dark-field radiography on a living organism to diagnose lung disease. This enables highly detailed images of the lung to be generated. This approach has the potential to detect diseases such as pulmonary emphysema at an earlier stage, than it is currently available.

Traditional radiographic procedures generate images based on the absorption of X-rays as they pass through the tissue. The newly developed technique of X-ray dark-field radiography uses new technology to track wave alteration during tissue transmission to generate higher resolution images.

With the help of this new technique, investigators from Helmholtz Zentrum Munchen (HMGU; Germany), working in cooperation with the Ludwig-Maximilians-Universitat Hospital (Munich, Germany) and the Technische Universitat Munchen (TUM; Germany), in particular Dr. Ali Onder Yildirim and Prof. Oliver Eickelberg, from the Comprehensive Pneumology Center (CPC; Munich, Germany), which is one of the centers of the German Center for Lung Research (DZL), achieved detailed images of soft tissue.

The study was conducted in cooperation with the Cluster of Excellence Munich-Center for Advanced Photonics (MAP). The scientists employed a small-animal scanner developed by Prof. Franz Pfeifer at the TUM to assess X-ray dark-field radiography on a living organism. For their investigations, they evaluated and compared images of the lung. “With X-ray dark-field radiography, structural changes in the lung tissue are visible at an early stage,” said Dr. Yildirim from the CPC/HMGU.

“Early detection of changes in the lung tissue will improve the diagnosis of lung diseases,” explained Dr. Felix Meinel, from the Institute of Clinical Radiology at the University Hospital Munich. The clinical application, in particular the diagnosis of lung diseases such as pulmonary emphysema or pulmonary fibrosis, will now be evaluated in further research.

Lung disorders are among the leading causes of death worldwide. Lifestyle, genetics, and environmental factors all play a role in their development. The work of the Helmholtz Zentrum München, the German Research Center for Environmental Health, focuses on the most common diseases with the goal of devising new strategies to their diagnosis, treatment, and prevention.

The study’s findings were published May 21, 2014, in the Investigative Radiology journal. Earlier findings were published November 13, 2013, in the journal Nature Scientific Reports.

Related Links:

Helmholtz Zentrum Munchen
Ludwig-Maximilians-Universitat Hospital
Technische Universitat Munchen


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
PACS Workstation
CHILI Web Viewer

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more